Chart Check: 40% down from highs, this pharma stock showing signs of bottoming out; time to buy?
The stock found support around Rs 502 earlier in February 2023 for the second time after March 2020 before recouping some losses. Most technical indicators are in an oversold zone and chances of a technical bounce back is on cards.
